Skip to main content
. 2010 Aug 26;6(8):e1001069. doi: 10.1371/journal.ppat.1001069

Figure 3. Pkc1 enables basal tolerance to ergosterol biosynthesis inhibitors in part via the MAPK cascade in Candida albicans.

Figure 3

(A) Deletion of PKC1, BCK1 or MKC1 reduces tolerance to fluconazole (FL), fenpropimorph (FN), and terbinafine (TB) in MIC assays. Assays were performed in YPD medium at 35°C with strains derived from the WT SN95. Data was analyzed after 72 hours growth as in Figure 1A. The minimum drug concentration that inhibits growth by 80% relative to the drug-free growth control (MIC80) is indicated for each strain. (B) Deletion of PKC1, but not MAPK components, creates a fungicidal combination with the ergosterol biosynthesis inhibitors in C. albicans. MIC assays with four-fold dilutions of FL, FN, and TB were performed in YPD and incubated for 48 hours at 35°C. Cells from the MIC assays were spotted onto YPD medium and incubated at 30°C for 48 hours before plates were photographed.